GlycoMimetics Inc (NAS:GLYC)
$ 0.3131 -0.0079 (-2.46%) Market Cap: 20.19 Mil Enterprise Value: 6.06 Mil PE Ratio: 0 PB Ratio: 1.78 GF Score: 30/100

Q4 2023 GlycoMimetics Inc Earnings Call Transcript

Mar 27, 2024 / 12:30PM GMT
Release Date Price: $3.18 (+11.58%)
Operator

Good morning, and thank you for joining the GlycoMimetics Q4 and full year 2023 earnings call. (Operator Instructions) I would now like to turn the call over to Christian Dinneen Long company counsel at GlycoMimetics. Please go ahead.

Christian Dinneen;Long
GlycoMimetics, Inc. - General Counsel

Good morning. Today we will review our business updates and financial results for the quarter and year ended December 31, 2023. The press release we issued this morning is available on the company's website at glycomimetics.com. This call is being recorded and a dial-in phone replay will be available for 24 hours after the close of the call. The webcast replay will also be available for 30 days in the Investors section of the company's website. On the call today from GlycoMimetics are Harout Semerijian, Chief Executive Officer, Brian Hahn, Chief Financial Officer, Edwin Rock, Chief Medical Officer, and Bruce Johnson, Chief Commercial Officer.

Today's call will include forward-looking statements based on our current expectations. Forward looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot